Sfoglia per AUTORE
FERRARI VD
Collezione AOU San Luigi di Orbassano

  

Items : 4

Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. in ESMO open / ESMO Open. 2022 Apr;7(2):100422. doi: 10.1016/j.esmoop.2022.100422. Epub 2022 Mar 7.
2022
AOU San Luigi di Orbassano

Laganà M; Grisanti S; Ambrosini R; Cosentini D; Abate A; Zamparini M; Ferrari VD; Gianoncelli A; Turla A; Canu L; Terzolo M; Tiberio GAM; Sigala S; Berruti A;

Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy. in Endocrine / Endocrine. 2021 Apr;72(1):20-23. doi: 10.1007/s12020-020-02569-x. Epub 2021 Jan 5.
2021
AOU San Luigi di Orbassano

Cosentini D; Grisanti S; Laganà M; Ferrari VD; Volta AD; Sigala S; Terzolo M; Berruti A;

2020
AOU San Luigi di Orbassano

Laganà M; Grisanti S; Cosentini D; Ferrari VD; Lazzari B; Ambrosini R; Sardini C; Volta AD; Palumbo C; Poliani PL; Terzolo M; Sigala S; Tiberio GAM; Berruti A;

Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. in European journal of endocrinology / Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.
2019
AOU San Luigi di Orbassano

Cosentini D; Badalamenti G; Grisanti S; Basile V; Rapa I; Cerri S; Spallanzani A; Perotti P; Musso E; Laganà M; Ferrari VD; Luppi G; Dalla Volta A; Incorvaia L; Sigala S; Russo A; Volante M; Terzolo M; Berruti A;